We are live on ! Find out more
HNGE

Hinge Health

180 hedge funds and large institutions have $2.36B invested in Hinge Health in 2025 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 74 increasing their positions, 29 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more call options, than puts

Call options by funds: $26.4M | Put options by funds: $9.78M

155% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 29

130% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 27

35% more capital invested

Capital invested by funds: $1.75B → $2.36B (+$608M)

23% more funds holding

Funds holding: 146180 (+34)

2.86% more ownership

Funds ownership: 131.23%134.08% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

Holders
180
Holders Change
+34
Holders Change %
+23.29%
% of All Funds
2.19%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
62
Increased
74
Reduced
29
Closed
27
Calls
$26.4M
Puts
$9.78M
Net Calls
+$16.6M
Net Calls Change
+$23.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
51
Geode Capital Management
Massachusetts
$7.45M -$351K -7,281 -4%
Victory Capital Management
52
Victory Capital Management
Texas
$7.4M -$2.69M -55,760 -26%
GIPM
53
G2 Investment Partners Management
New York
$6.97M -$1.85M -38,515 -20%
Citigroup
54
Citigroup
New York
$6.61M +$5.23M +108,509 +321%
IG
55
ING Group
Netherlands
$6.55M +$6.79M +141,000 New
ACA
56
Apis Capital Advisors
New York
$6.41M +$6.65M +138,000 New
FCMV
57
Foresite Capital Management VI
California
$6.27M
MA
58
Mutual Advisors
Nebraska
$6.04M +$6.26M +130,003 New
State Street
59
State Street
Massachusetts
$5.85M +$1.6M +33,151 +36%
OQS
60
Occudo Quantitative Strategies
Florida
$5.85M +$6.07M +125,946 New
SAM
61
Silvercrest Asset Management
New York
$5.79M +$1.3M +26,897 +28%
QT
62
Quantbot Technologies
New York
$5.76M +$4.25M +88,276 +247%
Norges Bank
63
Norges Bank
Norway
$5.21M +$5.41M +112,226 New
Jacobs Levy Equity Management
64
Jacobs Levy Equity Management
New Jersey
$5.03M +$4.48M +93,113 +615%
Fidelity International
65
Fidelity International
Bermuda
$4.85M +$1.44M +29,983 +40%
Principal Financial Group
66
Principal Financial Group
Iowa
$4.79M +$4.96M +103,057 New
AG
67
Algert Global
California
$4.53M +$4.7M +97,603 New
SSA
68
Schonfeld Strategic Advisors
New York
$4.23M +$4.39M +91,077 New
Two Sigma Investments
69
Two Sigma Investments
New York
$4.15M +$2.98M +61,845 +225%
Charles Schwab
70
Charles Schwab
California
$4.1M -$101K -2,101 -2%
QC
71
Quadrature Capital
United Kingdom
$4M +$3.94M +81,806 +1,875%
PCM
72
Palisade Capital Management
New Jersey
$3.94M +$4.09M +84,823 New
Raymond James Financial
73
Raymond James Financial
Florida
$3.82M +$22.3K +464 +0.6%
RCM
74
RA Capital Management
Massachusetts
$3.72M +$3.86M +80,113 New
CMF
75
Counterpoint Mutual Funds
California
$3.69M +$3.34M +69,276 +680%

HNGE Hedge Fund Activity: Q4 2025 in Review

180 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Hinge Health (HNGE) for Q4 2025, worth a combined $2.36B — up 35% from $1.75B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new HNGE positions and 27 closed out — a net gain of 35 holders — while 74 added to existing stakes and 29 trimmed.

The largest buyer was Jane Street, adding an estimated $73.3M. The largest seller was Coatue Management, exiting entirely with an estimated $231M sold.

  • 180 institutional investors held Hinge Health (HNGE) as of Q4 2025, up from 146 in Q3 2025.
  • Funds reported $2.36B of Hinge Health stock for Q4 2025, up 35% quarter-over-quarter.
  • 62 funds opened new Hinge Health positions in Q4 2025 and 27 closed out, a net change of +35 holders.
  • The largest Hinge Health buyer in Q4 2025 was Jane Street, an estimated $73.3M added.
  • The largest Hinge Health seller in Q4 2025 was Coatue Management, an estimated $231M sold.

Based on aggregated 13F filings for Q4 2025.